Traws Pharma, Inc. — Director's Dealing 2021

Jul 31, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2021-07-30

Reporting Person: MARINO JAMES J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-30	Stock Option (right to purchase)	$4.97	A	13000	Acquired	2031-07-30	Common stock (13000)	Direct

Footnotes

F1: These options vest 100% on the first anniversary of the grant date.